Good afternoon good people,
Well, well, well quite a mid-afternoon surprise 'response' from our vaunted yet humiliated (hydroxychloroquine EUA anyone?) FDA on why- in their own words- they did not grant LL an EUA or approval. Something concerning "trial design"... [For any Mamet fans out there, he would added the stage direction of sotto voice after this last quote].
I'm writing to let the uninitiated and unaware on this board know that what we received from the FDA this afternoon is what is known in professional poker circles as the hijack raising pot limit into the cutoff and the button on the turn.
To the part-time or weekend player this move appears to be a strong play, a show of extreme strength in semi late position on fourth street. The play maybe interpreted by the average player as a late position semi bluff. The play is an attempt to force out not only weaker hands who were looking to triple up a low pair on the turn OR catch a low card inside straight BUT the play is also designed to make the cutoff and the button fold *a stronger hand* to the hijack.
I'll save everyone here a Sklansky or Caro class and simply say the FDA IS THE WEAK HAND here at the table.
The FDA did NOT need to make this play BUT they did and the play feigns strength because the play fails to address the actual SAFETY profile of LL relative to those drugs that have ALREADY been granted EUA status and even those that the FDA has since withdrawn.
This last point is particularly astounding and imho it reveals exactly why the FDA did what it did.
The FDA does not have exclusivity on medical research nor drug trials. India, the Philippines and Brazil represent approx 20% of the world's population.
Covid-19 vaccines are not available en mass to these countries. I find it very curious that the FDA letter specifically mentions the "critical unmet medical need for new, effective treatments for COVID-19, especially for severe forms of the disease" but demures from mentioning their national champion- courtesy of Gilead.
I think India is the button in this international COVID-19 treatment poker game and India is holding big slick and the turn card was a same suit ace to his king.
Good luck FDA, you have bet into an over card hand holding pocket rockets that also has the high flush.
Nice move, sport...
TSOV
Well, well, well quite a mid-afternoon surprise 'response' from our vaunted yet humiliated (hydroxychloroquine EUA anyone?) FDA on why- in their own words- they did not grant LL an EUA or approval. Something concerning "trial design"... [For any Mamet fans out there, he would added the stage direction of sotto voice after this last quote].
I'm writing to let the uninitiated and unaware on this board know that what we received from the FDA this afternoon is what is known in professional poker circles as the hijack raising pot limit into the cutoff and the button on the turn.
To the part-time or weekend player this move appears to be a strong play, a show of extreme strength in semi late position on fourth street. The play maybe interpreted by the average player as a late position semi bluff. The play is an attempt to force out not only weaker hands who were looking to triple up a low pair on the turn OR catch a low card inside straight BUT the play is also designed to make the cutoff and the button fold *a stronger hand* to the hijack.
I'll save everyone here a Sklansky or Caro class and simply say the FDA IS THE WEAK HAND here at the table.
The FDA did NOT need to make this play BUT they did and the play feigns strength because the play fails to address the actual SAFETY profile of LL relative to those drugs that have ALREADY been granted EUA status and even those that the FDA has since withdrawn.
This last point is particularly astounding and imho it reveals exactly why the FDA did what it did.
The FDA does not have exclusivity on medical research nor drug trials. India, the Philippines and Brazil represent approx 20% of the world's population.
Covid-19 vaccines are not available en mass to these countries. I find it very curious that the FDA letter specifically mentions the "critical unmet medical need for new, effective treatments for COVID-19, especially for severe forms of the disease" but demures from mentioning their national champion- courtesy of Gilead.
I think India is the button in this international COVID-19 treatment poker game and India is holding big slick and the turn card was a same suit ace to his king.
Good luck FDA, you have bet into an over card hand holding pocket rockets that also has the high flush.
Nice move, sport...
TSOV
14
1
